Literature DB >> 25707861

Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study.

Alvaro Alonso1, Xuemei Huang, Thomas H Mosley, Gerardo Heiss, Honglei Chen.   

Abstract

OBJECTIVE: Autonomic dysfunction frequently occurs in the context of Parkinson disease (PD) and may precede onset of motor symptoms. Limited data exist on the prospective association of heart rate variability (HRV), a marker of autonomic function, with PD risk.
METHODS: We included 12,162 participants of the Atherosclerosis Risk in Communities study, a community-based cohort, without a diagnosis of PD at baseline (1987-1989) and with available HRV data (mean age = 54 years, 57% women). A 2-minute electrocardiogram was used to measure HRV. Incident PD was identified through 2008 from multiple sources, and adjudicated. Multivariable Cox models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of PD by quartiles of HRV measurements.
RESULTS: During a mean follow-up of 18 years, we identified 78 incident PD cases. Lower values of the root mean square of successive differences in normal-to-normal R-R intervals (rMSSD) and standard deviation of normal-to-normal R-R intervals (SDNN), markers of parasympathetic activity and total variability, respectively, were associated with higher PD risk during follow-up. In multivariate models, the HR (95% CI) of PD in the bottom quartiles of rMSSD and SDNN compared to the top quartiles were 2.1 (1.0-4.3) and 2.9 (1.4-6.1), respectively. Other measures of cardiac autonomic function, including mean R-R interval and frequency-domain measurements, were not associated with PD risk.
INTERPRETATION: In this prospective cohort, decreased HRV was associated with an increased risk of PD. Assessment of cardiac autonomic function may help identify individuals at risk for PD.
© 2015 American Neurological Association.

Entities:  

Mesh:

Year:  2015        PMID: 25707861      PMCID: PMC4529999          DOI: 10.1002/ana.24393

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  21 in total

Review 1.  Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment.

Authors:  K Ray Chaudhuri; Anthony H V Schapira
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

2.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control.

Authors:  S Akselrod; D Gordon; F A Ubel; D C Shannon; A C Berger; R J Cohen
Journal:  Science       Date:  1981-07-10       Impact factor: 47.728

3.  Profound cardiac sympathetic denervation occurs in Parkinson disease.

Authors:  Takeshi Amino; Satoshi Orimo; Yoshinori Itoh; Atsushi Takahashi; Toshiki Uchihara; Hidehiro Mizusawa
Journal:  Brain Pathol       Date:  2005-01       Impact factor: 6.508

4.  Cardiovascular physiology in premotor Parkinson's disease: a neuroepidemiologic study.

Authors:  Samay Jain; Thanh G Ton; Subashan Perera; Yan Zheng; Phyllis K Stein; Evan Thacker; Elsa S Strotmeyer; Anne B Newman; Will T Longstreth
Journal:  Mov Disord       Date:  2012-06-14       Impact factor: 10.338

5.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

Review 6.  Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis.

Authors:  Samay Jain; David S Goldstein
Journal:  Neurobiol Dis       Date:  2011-11-04       Impact factor: 5.996

7.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

8.  Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.

Authors:  Satoshi Orimo; Toshiki Uchihara; Ayako Nakamura; Fumiaki Mori; Akiyoshi Kakita; Koichi Wakabayashi; Hitoshi Takahashi
Journal:  Brain       Date:  2007-12-13       Impact factor: 13.501

Review 9.  Diagnosis and the premotor phase of Parkinson disease.

Authors:  Eduardo Tolosa; Carles Gaig; Joan Santamaría; Yaroslau Compta
Journal:  Neurology       Date:  2009-02-17       Impact factor: 9.910

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  26 in total

1.  Autonomic and electrocardiographic findings in Parkinson's disease.

Authors:  Christopher H Gibbons; David K Simon; Meilin Huang; Barbara Tilley; Michael J Aminoff; Jacquelyn L Bainbridge; Matthew Brodsky; Roy Freeman; John Goudreau; Robert W Hamill; Sheng T Luo; Carlos Singer; Aleksandar Videnovic; Ivan Bodis-Wollner; Pei S Wong
Journal:  Auton Neurosci       Date:  2017-04-14       Impact factor: 3.145

2.  Cardiac parasympathetic dysfunction in the early phase of Parkinson's disease.

Authors:  Masashi Suzuki; Tomohiko Nakamura; Masaaki Hirayama; Miki Ueda; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2016-11-29       Impact factor: 4.849

Review 3.  Advances in markers of prodromal Parkinson disease.

Authors:  Ronald B Postuma; Daniela Berg
Journal:  Nat Rev Neurol       Date:  2016-10-27       Impact factor: 42.937

4.  Association between heart rate variability and striatal dopamine depletion in Parkinson's disease.

Authors:  Tomomichi Kitagawa; Tadashi Umehara; Hisayoshi Oka; Tomotaka Shiraishi; Takeo Sato; Hiroki Takatsu; Atsuo Nakahara; Hiromasa Matsuno; Keiko Bono; Shusaku Omoto; Hidetomo Murakami; Renpei Sengoku; Yasuyuki Iguchi
Journal:  J Neural Transm (Vienna)       Date:  2021-09-24       Impact factor: 3.575

5.  Wearable sensor device-based detection of decreased heart rate variability in Parkinson's disease.

Authors:  Masashi Suzuki; Tomohiko Nakamura; Masaaki Hirayama; Masamichi Ueda; Mai Hatanaka; Yumiko Harada; Masahiro Nakatochi; Daisuke Nakatsubo; Satoshi Maesawa; Ryuta Saito; Koichi Fujiwara; Masahisa Katsuno
Journal:  J Neural Transm (Vienna)       Date:  2022-07-14       Impact factor: 3.850

6.  Pilot Study for Correlation of Heart Rate Variability and Dopamine Transporter Brain Imaging in Patients with Parkinsonian Syndrome.

Authors:  Devdutta S Warhadpande; Jiayan Huo; William A Libling; Carol Stuehm; Bijan Najafi; Scott Sherman; Hong Lei; Janet Meiling Roveda; Phillip H Kuo
Journal:  Sensors (Basel)       Date:  2022-07-05       Impact factor: 3.847

7.  Serum 25-hydroxyvitamin D concentrations in Mid-adulthood and Parkinson's disease risk.

Authors:  Srishti Shrestha; Pamela L Lutsey; Alvaro Alonso; Xuemei Huang; Thomas H Mosley; Honglei Chen
Journal:  Mov Disord       Date:  2016-04-19       Impact factor: 10.338

8.  Autonomic dysfunction in subjects at high risk for Parkinson's disease.

Authors:  Inga Liepelt-Scarfone; Andrea Pilotto; Katharina Müller; Christian Bormann; Katharina Gauss; Isabel Wurster; Johannes Streffer; Daniela Berg
Journal:  J Neurol       Date:  2015-11-03       Impact factor: 4.849

9.  Artificial Intelligence-Assisted Prediction of Late-Onset Cardiomyopathy Among Childhood Cancer Survivors.

Authors:  Fatma Güntürkün; Oguz Akbilgic; Robert L Davis; Gregory T Armstrong; Rebecca M Howell; John L Jefferies; Kirsten K Ness; Ibrahim Karabayir; John T Lucas; Deo Kumar Srivastava; Melissa M Hudson; Leslie L Robison; Elsayed Z Soliman; Daniel A Mulrooney
Journal:  JCO Clin Cancer Inform       Date:  2021-04

Review 10.  Prodromal Parkinson disease subtypes - key to understanding heterogeneity.

Authors:  Daniela Berg; Per Borghammer; Seyed-Mohammad Fereshtehnejad; Sebastian Heinzel; Jacob Horsager; Eva Schaeffer; Ronald B Postuma
Journal:  Nat Rev Neurol       Date:  2021-04-20       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.